A detailed history of Lsv Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Lsv Asset Management holds 14,000 shares of ABBV stock, worth $2.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,000
Previous 594,470 97.64%
Holding current value
$2.52 Million
Previous $102 Million 97.29%
% of portfolio
0.01%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $95.1 Million - $116 Million
-580,470 Reduced 97.64%
14,000 $2.77 Million
Q2 2024

Aug 06, 2024

SELL
$154.79 - $180.76 $5.39 Million - $6.29 Million
-34,800 Reduced 5.53%
594,470 $102 Million
Q1 2024

May 06, 2024

SELL
$159.82 - $182.1 $6.27 Million - $7.14 Million
-39,220 Reduced 5.87%
629,270 $115 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $14.5 Million - $16.3 Million
-105,400 Reduced 13.62%
668,490 $104 Million
Q3 2023

Nov 03, 2023

SELL
$133.59 - $154.65 $3.96 Million - $4.59 Million
-29,680 Reduced 3.69%
773,890 $115 Million
Q2 2023

Aug 02, 2023

SELL
$132.51 - $164.9 $86.9 Million - $108 Million
-655,510 Reduced 44.93%
803,570 $108 Million
Q1 2023

May 02, 2023

SELL
$144.61 - $166.54 $41.1 Million - $47.3 Million
-283,960 Reduced 16.29%
1,459,080 $233 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $140 Million - $168 Million
-1,014,922 Reduced 36.8%
1,743,040 $282 Million
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $14.8 Million - $16.9 Million
-109,956 Reduced 3.83%
2,757,962 $370 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $57.6 Million - $73.2 Million
-418,514 Reduced 12.73%
2,867,918 $439 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $6.57 Million - $8.15 Million
-49,759 Reduced 1.49%
3,286,432 $533 Million
Q4 2021

Jan 28, 2022

SELL
$107.43 - $135.93 $7.92 Million - $10 Million
-73,700 Reduced 2.16%
3,336,191 $452 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $15.9 Million - $18.1 Million
149,903 Added 4.6%
3,409,891 $368 Million
Q2 2021

Aug 04, 2021

BUY
$105.21 - $117.21 $6.13 Million - $6.83 Million
58,287 Added 1.82%
3,259,988 $367 Million
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $26.4 Million - $29 Million
-257,673 Reduced 7.45%
3,201,701 $346 Million
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $20.5 Million - $27.7 Million
-254,500 Reduced 6.85%
3,459,374 $371 Million
Q3 2020

Oct 23, 2020

SELL
$85.91 - $100.83 $4.99 Million - $5.86 Million
-58,099 Reduced 1.54%
3,713,874 $325 Million
Q2 2020

Aug 05, 2020

SELL
$73.37 - $98.18 $130 Million - $174 Million
-1,773,550 Reduced 31.98%
3,771,973 $370 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $22.4 Million - $34 Million
-347,664 Reduced 5.9%
5,545,523 $423 Million
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $10.5 Million - $13.2 Million
-145,863 Reduced 2.42%
5,893,187 $522 Million
Q3 2019

Nov 07, 2019

SELL
$62.98 - $75.72 $29.3 Million - $35.3 Million
-465,876 Reduced 7.16%
6,039,050 $457 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $5.48 Million - $7.01 Million
83,454 Added 1.3%
6,504,926 $473 Million
Q1 2019

May 07, 2019

BUY
$77.14 - $90.79 $12.1 Million - $14.3 Million
157,043 Added 2.51%
6,421,472 $518 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $1.28 Million - $1.58 Million
-16,418 Reduced 0.26%
6,264,429 $578 Million
Q3 2018

Nov 06, 2018

BUY
$88.91 - $98.84 $12.5 Million - $13.9 Million
140,560 Added 2.29%
6,280,847 $594 Million
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $537,243 - $635,680
5,984 Added 0.1%
6,140,287 $569 Million
Q1 2018

May 04, 2018

SELL
$92.01 - $123.21 $17 Million - $22.8 Million
-185,000 Reduced 2.93%
6,134,303 $581 Million
Q4 2017

Feb 01, 2018

SELL
$89.56 - $98.21 $46.9 Million - $51.4 Million
-523,470 Reduced 7.65%
6,319,303 $0
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $478 Million - $611 Million
6,842,773
6,842,773 $608 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lsv Asset Management Portfolio

Follow Lsv Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.